Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Generics Last? Medco Accused Of Shifting Away From Mature Brands

  • News

Executive Summary

Medco makes a practice of transferring market share away from brands that are about to lose exclusivity, a False Claims Act suit unsealed June 23 alleges

You may also be interested in...



Medco Injunction Changes Equation For Switches: PBM Must Cover All Costs

Medco will pay all "drug interchange-related health care costs" incurred by consumers under a consent order entered April 26

Medco Injunction Changes Equation For Switches: PBM Must Cover All Costs

Medco will pay all "drug interchange-related health care costs" incurred by consumers under a consent order entered April 26

Medco Says “Drug Switching” Charges Are Old News, Should Be Dismissed

Medco believes its 1998 consent agreement with the Federal Trade Commission should protect the company from "whistleblower" allegations that it engaged in inappropriate drug switching practices

Table

View full table

Tags:
Latest Headlines

Global Pharma Guidance Tracker – March 2024

EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

See All
UsernamePublicRestriction

Register

PS042047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By